NEW YORK (GenomeWeb News) – Maxygen has received a $3.4 million grant from the US Department of Defense to develop its genetic reshuffling technology through a collaboration with the DNA-based vaccine services provider Aldevron, the company said today.
 
The firm’s ParallelaVax system is used for rapid, high-throughput screening of vaccine candidates in animals.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.